Results 261 to 270 of about 83,265 (304)

Cholecystokinin (CCK) Assays

Current Protocols in Pharmacology, 1999
AbstractCholecystokinin (CCK) is a peptide that acts as a peripheral hormone and as a central neurotransmitter. To date, two distinct receptors have been identified for CCK using structural and operational criteria; CCK1 and CCK2 (formerly CCKA and CCKB, respectively).
D G, Trist, M, Corsi
openaire   +2 more sources

[Cholecystokinin and cholecystokinin receptor].

Nihon rinsho. Japanese journal of clinical medicine, 1996
Cholecystokinin (CCK) act as hormones and neuropeptides on central and peripheral CCK receptors. The application of modern molecular biological techniques has identified two CCK receptors, CCK-A receptor (CCKAR) and CCK-B/gastrin receptor (CCKBR). The genes of CCKAR and CCKBR consist of five exons interrupted by four introns.
openaire   +1 more source

Cholecystokinin/opioid interactions

Brain Research, 1999
Cholecystokinin (CCK) acts as an anti-opioid peptide. The mechanisms of CCK-opioid interaction under normal and pathological conditions were examined with various techniques. Nerve injury induces upregulation of CCK mRNA and CCK2 receptors in sensory neurons. The involvement of CCK in spinal nociception in normal and axotomized rats was examined.
Z, Wiesenfeld-Hallin, G, de Araúja Lucas, P, Alster, X J, Xu, T, Hökfelt   +4 more
openaire   +2 more sources

Cholecystokinin and cholecystokinin receptors

Journal of Gastroenterology, 2003
Kyoko, Miyasaka, Akihiro, Funakoshi
openaire   +2 more sources

Cholecystokinin Antagonists

Annual Review of Pharmacology and Toxicology, 1991
G N, Woodruff, J, Hughes
openaire   +2 more sources

Cholecystokinin-dopamine intearctions

Trends in Pharmacological Sciences, 1991
Cholecystokinin (CCK) coexists with dopamine in a large proportion of the ventral tegmental and substantia nigra neurons in rodents and primates. In this review Jacki Crawley integrates the neurophysiological, behavioral, and release studies which demonstrate both excitatory effects of CCK, and facilitatory modulating effects of CCK on the inhibitory ...
openaire   +2 more sources

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.

Journal of Medicinal Chemistry, 1988
B. E. Evans, K. Rittle, M. Bock, R. M. Dipardo, R. Freidinger, W. L. Whitter, G. F. Lundell, D. Veber, P. Anderson, R. Chang, V. J. Lotti, D. Cerino, Tsing-Bau Chen, P. Kling, K. Kunkel, J. Springer, J. Hirshfield   +16 more
semanticscholar   +1 more source

Cholecystokinin Cholecystoqraphy

Radiology, 1969
M H, Nathan, A, Newman, J, McFarland, D J, Murray   +3 more
openaire   +2 more sources

Cholecystokinin decreases food intake in rats.

Journal of Comparative and Physiological Psychology, 1973
J. Gibbs, R. Young, Gerard P. Smith
semanticscholar   +1 more source

Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet‐induced obese and leptin‐deficient rodents

Diabetes, obesity and metabolism, 2015
James L. Trevaskis, Chengzao Sun, J. Athanacio, L. D'souza, M. Samant, K. Tatarkiewicz, Peter S. Griffin, Carrie R. Wittmer, Yan Wang, Chung-Hua Teng, Bruce Forood, D. Parkes, J. D. Roth   +12 more
semanticscholar   +1 more source